Machine Learning Model for Pathology Image Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing pathology images using artificial intelligence algorithms face challenges due to the need for large amounts of labeled training data, which is costly and time-consuming to obtain, especially for new biomarkers and low-prevalence cancer types.

Innovation Solution

A method and system that utilize a machine learning model trained on a training data set generated from heterogeneous pathology data sets, allowing for accurate analysis of various types of pathology images without the need for extensive retraining for new image types.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If artificial intelligence algorithms are trained using pathology images labeled with medical knowledge, then accurate prediction results are achieved, but cost and time increase due to the need for medical experts to build training data

Engineering Contradiction:
Improveprediction accuracyVSAvoidtraining data preparation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The training data is segmented into two distinct domains: first domain data (e.g., PD-L1 IHC stained images) and second domain data (e.g., H&E stained images or new biomarker images). The machine learning model is trained to learn domain-specific features separately, then integrated to achieve accurate predictions while reducing the need for extensive labeled data in each individual domain.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The machine learning model is designed with multi-functionality to handle multiple types of pathology images from different domains. By training on heterogeneous data sets simultaneously, the model becomes universal and can accurately predict results for various cancer types and staining methods without requiring separate training processes for each domain.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If artificial intelligence algorithms are trained using pathology images from new biomarkers, then analysis capability for new targets is achieved, but sufficient training data cannot be ensured in a short period due to limited clinical data

Engineering Contradiction:
Improvenew biomarker analysis capabilityVSAvoidtraining data volume
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The patent merges data from multiple domains into a unified training data set. By combining first domain pathology data (which may have sufficient clinical data) with second domain pathology data (new biomarkers with limited data), the model learns transferable features that enable accurate analysis of new biomarkers even when training data for those specific biomarkers is scarce.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The machine learning model performs preliminary learning on well-established biomarkers with abundant clinical data (first domain), acquiring general pathology image recognition capabilities. This preliminary training enables the model to quickly adapt to new biomarkers with limited data, as the foundational skills are already established.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If artificial intelligence model is trained using small amount of data for low-prevalence cancer types, then model training is completed faster, but the model may not be properly trained or becomes biased toward specific training data set

Engineering Contradiction:
Improvemodel training speedVSAvoidmodel training quality
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The first domain pathology data acts as an intermediary that bridges the gap for low-prevalence cancer types. By training on this larger, more diverse data set first, the model develops robust generalization capabilities that prevent overfitting to small data sets, while still enabling faster training compared to traditional methods that would require extensive data collection for rare cancers.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12266196B2Method and system for analyzing pathology image
Publication Date: 2025.04.01 LUNIT
  • US12266196B2 patent drawing
  • US12266196B2 patent drawing
  • US12266196B2 patent drawing

AI summary

Provided is a method for analysing a pathology image, which is performed by at least one processor and includes acquiring a pathology image, inputting the acquired pathology image into a machine learning model and acquiring an analysis result for the pathology image from the machine learning model, and outputting the acquired analysis result, in which the machine learning model is a model trained by using a training data set generated based on a first pathology data set associated with a first domain and a second pathology data set associated with a second domain different from the first domain.